Skip to main content

Spectrum: Autism Research News

Tag: hyperactivity

November 2010

Making quick decisions more challenging for kids with autism

by  /  18 November 2010

Children with autism show more activity in a brain region important for making decisions under changing circumstances, according to a poster presented Monday at the Society for Neuroscience annual meeting in San Diego.


Lithium targets key enzyme to improve fragile X symptoms

by  /  18 November 2010

Lithium ameliorates some of the cognitive and behavioral deficits associated with fragile X syndrome by blocking GSK-3, an enzyme that plays a key role in development, researchers said Wednesday at the Society for Neuroscience annual meeting in San Diego.

August 2010

Venn diagnoses

by  /  25 August 2010

Three articles published in the past few weeks show that diagnostic categories marked off neatly on the page often bleed together messily in the clinic.

April 2010

Researchers probe genetic overlap between ADHD, autism

by  /  22 April 2010

Attention deficit hyperactivity disorder (ADHD) and autism may have more in common than childhood onset and a few similar symptoms. New research suggests the conditions share genetic roots.

March 2010

Autism and fragile X feature immune signatures

by  /  30 March 2010

Scientists have identified distinct blood signatures of cytokines — proteins that control communication between cells of the immune system — in individuals with fragile X syndrome and autism.


Studies challenge link between premature birth and autism

by  /  8 March 2010

The proposed connection between premature birth and autism may be more complicated than it seems, according to a new report. Early birth may not cause classically defined autism but, rather, may predispose children to autism-like symptoms that are part of a larger syndrome, the researchers say.

1 Comment
December 2009

Approving news

by  /  4 December 2009

In the spirit of Thanksgiving, those dealing with autism received some welcome news last week: The U.S. Food and Drug Administration approved Abilify (aripiprazole) as a treatment for autism-related irritability.